VERU Veru Inc.

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.

$8.52  +0.04 (0.41%)
As of 06/22/2021 15:59:16 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  79,683,554
Average volume:  781,723
Market cap:   $670,935,525
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92536C103
ISIN:        US92536C1036
Sedol:      BDFBQ66
Valuation   (See tab for details)
PE ratio:   -1,419.01
PB ratio:   4.35
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy